Privacy & data
Does anti-doping violate medical privacy?
Open access · cc by · source: Europe PMC
Since WADA (1999), athletes must report whereabouts and urinate in view for samples — a surveillance and testing regime the authors say clashes with medical-ethics norms and received privacy.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.
Discoveries this paper informs or conflicts with
- Anti-doping surveillance would be unacceptable in any setting but this one
This paper informs this development.
Inspect source passages
Does anti-doping violate medical privacy?
These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.
Agency?
World Anti Doping Agency – Agence Mondiale Anti-Dopage (WADA-AMA) and its anti-doping regulation, athletes in several sports are obliged to keep the author
Whereabouts?
athletes in several sports are obliged to keep the authorities informed of their day-to-day whereabouts so that they can be obliged to urinate in full view
Key findings
Such observed collection would be unacceptable in any other setting except perhaps imprisonment, yet is treated as ethical in elite sport. Privacy is the casualty of the testing regime.
Methodology
They reconstruct the WADA-AMA framework, the whereabouts rule and observed urination, and argue the normative framework plays out as costly surveillance increasingly at odds with medical ethics.
Limitations
This is a 2007 critical appraisal, not a new prevalence study of doping. It does not design an alternative code in detail.
Related papers in this topic
Same topic cluster — not a recommendation engine.